Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Standard first-line curative regimen for Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma, and High-Grade B-cell Lymphomas.
First-line treatment of Advanced Follicular Lymphoma and Indolent B-cell Non-Hodgkin Lymphomas.
Primary Mediastinal Large B-Cell Lymphoma, Double-Hit / High-Grade B-cell Lymphoma, and HIV-associated Lymphoma.
Relapsed or refractory Diffuse Large B-cell Lymphoma prior to autologous stem cell transplantation.
PSMA-positive Metastatic Castration-Resistant Prostate Cancer, Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs), and Pheochromocytoma.
HR-positive Breast Cancer in adjuvant, metastatic, and chemoprevention settings.
Colorectal Cancer, Non-Small Cell Lung Cancer, Glioblastoma, Renal Cell Carcinoma, Gastric Cancer, and Ovarian Cancer.
Prevention and management of chemotherapy-related organ toxicities and complications.
Targeted treatment of solid tumors and hematologic malignancies.
Approved for use in oncology care according to FDA-approved indications.
Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.
Prevention of HPV-associated cervical, vulvar, vaginal, anal, and oropharyngeal cancers.